A randomized phase II non-comparative study of PF-04691502 and gedatolisib (PF-05212384) in patients with recurrent endometrial cancer
del Campo, Josep María, Birrer, Michael, Davis, Craig, Fujiwara, Keiichi, Gollerkeri, Ashwin, Gore, Martin, Houk, Brett, Lau, Susie, Poveda, Andres, González-Martín, Antonio, Muller, Carolyn, Muro, KeLanguage:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2016.04.019
Date:
April, 2016
File:
PDF, 733 KB
english, 2016